Projects per year
Personal profile
Personal profile
Dr. Eagar received his PhD in immunology and molecular pathogenesis from the Northwestern University Medical School in Chicago in 2001. He then completed an immunology fellowship at the University of California at San Francisco and an HLA fellowship at Houston Methodist Hospital. Dr. Eagar was an assistant professor in the Department of Pathology and Immunology at The University of Texas Southwestern Medical Center in Dallas before joining the Department of Pathology and Genomic Medicine here in 2013.
Research interests
Dr. Eagar is board certified in histocompatibility by the American Board of Histocompatibility and Immunogenetics. His research interests include identifying immune processes involved in the pathogenesis of multiple sclerosis and transplant rejection, with a focus on finding novel regulatory pathways involved in T cell activation that might be harnessed for therapeutic intervention.
Research Area Keywords
- Infectious Disease & Pathology
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 2 Finished
-
Defining Immunology Frailty as a Predictor of Human Liver Allograft Recipient Futility
Chen, W., Eagar, T. N., Ghobrial, R. M., Graviss, E. A., Gupte, A. A., Hamilton, D. J. & Li, X. C.
4/10/19 → 8/31/19
Project: Federal Funding Agencies
-
Modulating B and T cell functions in EAE through gamma secretase and Notch
Natl Inst of Neuro Disorders and Stroke
8/1/13 → 5/31/18
Project: Federal Funding Agencies
-
Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates
Fida, N., Eagar, T. N., Yun, A. N., Rogers, A. W., Nguyen, D. T., Graviss, E. A., Ishaq, F., DiPaola, N. R., Kim, J., Janardhana, G., Kassi, M., Yousefzai, R., Suarez, E. E., Bhimaraj, A., Krisl, J. C. & Guha, A., Feb 2024, In: Clinical Transplantation. 38, 2, p. e15249 e15249.Research output: Contribution to journal › Article › peer-review
-
Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients
Vasileiou, S., Hill, L. Q., Kuvalekar, M., Workineh, A. G., Watanabe, A., Velazquez, Y., Lulla, S., Mooney, K., Lapteva, N., Grilley, B. J., Heslop, H. E., Rooney, C. M., Brenner, M. K., Eagar, T. N., Carrum, G., Grimes, K. A., Leen, A. M. & Lulla, P., Jul 1 2023, In: Haematologica. 108, 7, p. 1840-1850 11 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Scopus citations -
COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohort
Roll, G. R., Bray, R. A., Cooper, M., Eagar, T. N., Gebel, H. M., Vranic, G. M., Hitchman, K. M. K., Houp, J., Kamoun, M., Killian, J., Kim, J., Kumar, V., Levine, M., Lovasik, B. P., Lunow-Luke, T., Parsons, R. F., Pattanayak, V., Ranch, D., Shah, A., Stock, P. G., & 6 others , Apr 2023, In: Human Immunology. 84, 4, p. 278-285 8 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Deceased donor vein extension grafts for right living donor kidney transplantation
Meinders, A. M., Knight, R., Eagar, T. N., Hobeika, M., Podder, H., Gaber, A. O. & Yi, S. G., Aug 2023, In: Clinical Transplantation. 37, 8, e14963.Research output: Contribution to journal › Article › peer-review
-
Exome Sequencing Implicates DGKZ , ESRRA , and GXYLT1 for Modulating Granuloma Formation in Crohn Disease
Harris, R. A., Bush, A. H., Eagar, T. N., Qian, J., Greenwood, M. P., Opekun, A. R., Baldassano, R., Guthery, S. L., Noe, J. D., Otley, A., Rosh, J. R., Kugathasan, S. & Kellermayer, R., Sep 1 2023, In: Journal of pediatric gastroenterology and nutrition. 77, 3, p. 354-357 4 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations